About bg medicine inc - BGMD
BG Medicine, Inc. is a life sciences company, which engages in the provision of developing and delivering innovative solutions for healthcare providers that provide insight and transform the clinical care of heart failure and related disorders. The firm distributes products such as BGM Galectin-3 to clinical laboratories, hospitals, and healthcare providers. The company was founded in February 2000 by Jan van der Greef and is headquartered in Waltham, MA.
BGMD At a Glance
BG Medicine, Inc.
303 Wyman Street
Waltham, Massachusetts 02451
| Phone | 1-781-890-1199 | Revenue | 1.57M | |
| Industry | Medical Specialties | Net Income | -5,303,000.00 | |
| Sector | Health Technology | Employees | 5 | |
| Fiscal Year-end | 12 / 2016 | |||
| View SEC Filings |
BGMD Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 2.24 |
| Price to Book Ratio | N/A |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -1.043 |
| Enterprise Value to Sales | 2.922 |
| Total Debt to Enterprise Value | N/A |
BGMD Efficiency
| Revenue/Employee | 313,200.00 |
| Income Per Employee | -1,060,600.00 |
| Receivables Turnover | 8.652 |
| Total Asset Turnover | 0.425 |
BGMD Liquidity
| Current Ratio | 1.653 |
| Quick Ratio | 1.531 |
| Cash Ratio | 1.292 |
BGMD Profitability
| Gross Margin | 67.752 |
| Operating Margin | -285.632 |
| Pretax Margin | -338.633 |
| Net Margin | -338.633 |
| Return on Assets | -144.064 |
| Return on Equity | -902.638 |
| Return on Total Capital | -858.091 |
| Return on Invested Capital | -902.638 |
BGMD Capital Structure
| Total Debt to Total Equity | N/A |
| Total Debt to Total Capital | N/A |
| Total Debt to Total Assets | N/A |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | N/A |